Cascade screening for familial hypercholesterolemia and the use of genetic testing

JAMA - Journal of the American Medical Association

Volumn 318, Issue 4, 2017, Pages 381-382

  Knowles, Joshua W ^a,b   Rader, Daniel J ^b,c   Khoury, Muin J ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FH Foundation   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; GENETIC SCREENING; GENETICS; HUMAN; HYPERLIPOPROTEINEMIA TYPE II; MALE; PEDIGREE; PROCEDURES;

FEMALE; GENETIC TESTING; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; PEDIGREE;

EID: 85027580655     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.8543     Document Type: Article

References (10)

1. Gidding SS, Champagne MA, de Ferranti SD, et al. The agenda for familial hypercholesterolemia. Circulation. 2015;132(22):2167-2192.
2. Wald DS, Bestwick JP, Morris JK, et al. Child-parent familial hypercholesterolemia screening in primary care. N Engl J Med. 2016;375 (17):1628-1637.
3. Safarova MS, Liu H, Kullo IJ. Rapid identification of familial hypercholesterolemia from electronic health records. J Clin Lipidol. 2016;10(5):1230-1239.
4. Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, et al. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357(9251):165-168.
5. DeMott K, Nherera L, Shaw EJ, et al. Clincial Guidelines and Evidence Review for Familial Hypercholesterolemia: the Identification and Management of Adults and Children With Familial Hypercholesterolemia. London, England: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2008.
6. Perez de Isla L, Alonso R, Watts GF, et al. Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia. J Am Coll Cardiol. 2016;67(11):1278-1285.
7. Lozano P, Henrikson NB, Dunn J, et al. Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia. JAMA. 2016;316(6):645-655.
8. Abul-Husn NS, Manickam K, Jones LK, et al. Genetic identification of familial hypercholesterolemia within a single U.S. health care system. Science. 2016;354(6319):aaf7000.
9. Wonderling D, Umans-Eckenhausen MA, Marks D, et al. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in the Netherlands. Semin Vasc Med. 2004;4(1):97-104.
10. Nherera L, Marks D, Minhas R, et al. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Heart. 2011;97(14):1175-1181.